A randomized, placebo-controlled trial of the use of an inhibitor of Aquaporin-1 for the treatment of heart failure with preserved ejection fraction-the BACOPEF trial
2020
Brussel
Steun voor het project 'A randomized, placebo-controlled trial of the use of an inhibitor of Aquaporin-1 for the treatment of heart failure with preserved ejection fraction-the BACOPEF trial'.
Ondersteuning
€ 79.587
Blijf op de hoogte van nieuwe ondersteunde individuen of organisaties
